Kura Oncology, Inc. (KURA) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -85.85M | 117.27M | -80.63M | -28.78M | -71.93M | 269.13M | -43.44M | -42.53M | -48.84M | -34.31M | -29.03M | -25.62M |
| Operating CF Margin % | -470.05% | 676.47% | -388.56% | -188.23% | -509.83% | 499.47% | - | - | - | - | - | - |
| Operating CF Growth % | -19.36% | -56.43% | -85.61% | 32.34% | -47.26% | 884.46% | -49.65% | -66.02% | -36.16% | -29.32% | -38.16% | 15.57% |
| Net Income | -73.33M | -81M | -74.12M | -66.12M | -57.43M | -19.22M | -54.4M | -50.84M | -49.52M | -42.79M | -38.6M | -37.17M |
| Depreciation & Amortization | 355K | 1.68M | 164K | 224K | 241K | 204K | 208K | 202K | 234K | 214K | 216K | 213K |
| Stock-Based Compensation | 0 | 11.35M | 10.96M | 6.95M | 7.84M | 8.63M | 8.32M | 8.43M | 8.51M | 7.17M | 7.09M | 6.99M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5M | 0 | 0 |
| Other Non-Cash Items | 7.62M | -2.56M | 26.6M | -5.69M | -2.53M | -2.75M | 2.37M | -3.42M | -3.15M | -7.61M | 1.16M | 2.12M |
| Working Capital Changes | -20.5M | 187.8M | -44.24M | 35.86M | -20.05M | 282.26M | 59K | 3.1M | -4.92M | 3.71M | 1.1M | 2.23M |
| Change in Receivables | -544K | 27.13M | -31.36M | 44.17M | -46.69M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | -430K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 2.03M | -10.31M | 0 | 0 | -5.43M | 12.7M | 0 | -50K | -3.13M | 7.65M | 0 | 0 |
| Cash from Investing | -24.23M | -64.6M | 93.97M | 58.94M | -101.41M | -94.95M | 45.53M | 43.17M | -95.34M | 42.2M | 8.56M | -46.33M |
| Capital Expenditures | -128K | -2.32M | -2.57M | -1.46M | -292K | -372K | 0 | -16K | -84K | -16K | -20K | -96K |
| CapEx % of Revenue | 0.7% | 13.39% | 12.37% | 9.54% | 2.07% | 0.69% | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -26.49K | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 96.53M | 60.4M | 0 | 0 | 45.53M | 0 | 0 | 26.49K | 8.58M | -46.23M |
| Cash from Financing | 69K | 1.14M | 0 | 515K | 143K | 806K | 2.2M | 3.04M | 148.37M | 691K | 84K | 94.01M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 69K | 1.14M | 0 | 0 | 143K | 806K | 0 | 3.04M | 145.81M | 691K | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 515K | 0 | 0 | 2.2M | 0 | 2.56M | 0 | 84K | 94.01M |
| Net Change in Cash | -110.02M | 53.81M | 13.34M | 30.68M | -173.19M | 174.98M | 4.3M | 3.68M | 4.19M | 8.58M | -20.38M | 22.07M |
| Free Cash Flow | -85.98M | 114.95M | -83.19M | -30.23M | -72.22M | 268.76M | -43.44M | -42.55M | -48.93M | -34.32M | -29.05M | -25.71M |
| FCF Margin % | -470.75% | 663.08% | -400.93% | -197.77% | -511.9% | 498.78% | - | - | - | - | - | - |
| FCF Growth % | -19.06% | -57.23% | -91.51% | 28.94% | -47.6% | 883.01% | -49.55% | -65.46% | -36.26% | -29.32% | -35.79% | 15.76% |
| FCF per Share | -0.97 | 1.31 | -0.95 | -0.35 | -0.83 | 3.08 | -0.50 | -0.49 | -0.58 | -0.44 | -0.38 | -0.37 |
| FCF Conversion (FCF/Net Income) | 1.17x | -1.45x | 1.09x | 0.44x | 1.25x | -14.00x | 0.80x | 0.84x | 0.99x | 0.80x | 0.75x | 0.69x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |